admin
PR Newswire
  • February 11, 2021

Iterative Scopes Announces Partnership with Eli Lilly and Company to Advance AI Applications for Inflammatory Bowel Disease (IBD) Clinical Trials

Iterative Scopes Announces Partnership with Eli Lilly and Company to Advance AI Applications for Inflammatory Bowel Disease (IBD) Clinical Trials
Related Stories

Press Releases

  • April 28, 2022
Iterative Scopes Announces the Acquisition of Clinical Research Strategy Group and Precision Research
Read more

Press Releases

  • February 8, 2022
Iterative Scopes Announces AI-Driven Data Sharing Agreement with Pfizer to Advance IBD Clinical Trials
Read more

Press Releases

  • January 19, 2022
Iterative Scopes Announces $150 Million Series B to Advance AI-Driven Precision Medicine for Gastroenterology
Read more
Company
Newsletter
Follow us

© 2024 Iterative Health. All rights reserved